$IBIO Unlike every other US company, $IBIO is getting better support because of the agreement with CC Pharmimg. The fact that the middle class in China is growing and they are able to produce the Generic for the population has helped $IBIO a lot. Also, IBIO CDMO "fast pharming" in Texas, since dose vaccine and 2 vaccines should make everyone feel very bullish. To have the access to CC Pharmimg/China pipeline is really unique, given the issues we are having with China. I assume we should hear something soon, hopefully this week about the trials.